The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis

Title
The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis
Authors
Keywords
GLP-1R, Liraglutide, PKA/CREB pathway, Inflammation, Osteoarthritis
Journal
Journal of Inflammation-London
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-06
DOI
10.1186/s12950-019-0218-y

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now